Fridays vs Ivy Rx

Neither Fridays nor Ivy Rx has an FDA warning letter on record. On compounded tirzepatide injection, Ivy Rx costs $744 less a year at standing rates: $297 a month against $359 a month at Fridays. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Ivy Rx

Fridays logo

Fridays

5.8/10

Ivy Rx logo

Ivy Rx

7.3/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$197/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Neither Fridays nor Ivy Rx pays us. Links to them earn nothing. Scores: Fridays 5.8, Ivy Rx 7.3. How we are paid

What the record shows

  1. 01

    Neither Fridays nor Ivy Rx has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Ivy Rx names no compounding pharmacy in our record.

  3. 03

    On compounded tirzepatide injection, Ivy Rx costs $744 less a year at standing rates: $297 a month against $359 a month at Fridays. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for brand-name semaglutide pen and brand-name tirzepatide pen.

  5. 05

    Ivy Rx lists all 50 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Ivy Rx

Compounded semaglutide injection

$249/mo

$2,988 a year

$197/moLower

$2,364 a year

Compounded tirzepatide injection

$359/mo

$4,308 a year

$297/moLower

$3,564 a year

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
All transactions are final; no returns
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Fridays: October 30, 2026. Ivy Rx: July 10, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Ivy Rx does not price
  • Names its compounding pharmacy
  • Publishes no state list

The case for Ivy Rx

7.3/10
  • $624 a year less on compounded semaglutide injection
  • $744 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy

Scores

Fridays 5.8 · Ivy Rx 7.3 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
7.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Ivy Rx: questions

Neither Fridays nor Ivy Rx has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Ivy Rx names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Ivy Rx, by $624 a year at standing rates. Fridays: $249 a month, about $2,988 a year. Ivy Rx: $197 a month, about $2,364 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Ivy Rx states you can cancel at any time; refunds: all transactions are final; no returns.
Neither Fridays nor Ivy Rx pays us. Links to them earn nothing. Scores: Fridays 5.8, Ivy Rx 7.3.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks